Recommends a vision and leads the strategic direction of the pharmaceutical development function; overseeing formulation, drug product development, manufacturing readiness, and CMC innovation across the portfolio. Ensures efficient progression of assets from early development through commercialization while aligning with corporate goals, regulatory requirements, and industry trends. Serves as a key advisor to executive leadership on development strategy, manufacturing technologies, and portfolio decisions, while building organizational capabilities and developing future leaders. Drives cross-functional initiatives and external collaborations, fostering innovation, operational excellence, and a strong patient-focused culture. Partners with leaders across Clinical, Regulatory, Operations, Quality, Safety, and Commercial to ensure CMC strategies, risks, and mitigation plans are communicated in support of global filings and approvals.